TNFα polymorphisms and risk of psoriatic arthritis

Annals of the Rheumatic Diseases

Volumn 65, Issue 7, 2006, Pages 919-923

  Rahman, P ^a,b   Siannis, F ^c   Butt, C ^b   Farewell, V ^c   Peddle, L ^b   Pellett, F ^d   Gladman, D ^d  

^a St Clare's Mercy Hospital   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANADA; CONTROLLED STUDY; DNA FLANKING REGION; DNA POLYMORPHISM; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; TIME OF FLIGHT MASS SPECTROMETRY; CLINICAL TRIAL; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; MIDDLE AGED; MULTICENTER STUDY; STATISTICAL MODEL;

ARTHRITIS, PSORIATIC; CANADA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745743481     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.039164     Document Type: Article

References (22)

1. Gladman DD, Rahman P. Psoriatic arthritis. In:Ruddy S, Harris ED, Sledge CB, Budd RC, Sergent JS, editors. Kelly's textbook of rheumatology, 6th edition. Philadelphia: WB Sounders Co, 2001:1071-9.
2. AM, Cookson WOCM. The genetics of psoriasis, psoriatic arthritis, and atopic dermatitis. Hum Mol Genet 2004;13:R43-55.
3. Kane D, FitzGerald O. Tumor necrosis factor-alpha in psoriasis and psoriatic arthritis: a clinical, genetic, and histopathologic perspective. Curr Rheumatol Rep 2004;6:292-8.
4. Danning CL, Illei GG, Hitchon C, Greer MR, Boumpas DT, McInnes IB. Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum 2000;43:1244-56.
5. Partsch G, Steiner G, Leeb BF, Dunky A, Broll H, Smolen JS. Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid. J Rheumatol 1997;24:518-23.
6. Mease P. TNFα therapy in psoriatic arthritis and psoriasis. Ann Rheum Dis 2004;63:755-8.
7. Hohler T, Grossmann S, Stradmann-Bellinghausen B, Kaluza W, Reuss E, de Vlam K, et al. Differential association of polymorphisms in the TNFα region with psoriatic arthritis but not psoriasis. Ann Rheum Dis 2002;61:213-18.
8. Hohler T, Kruger A, Schneider PM, Schopf RE, Knop J, Rittner C, et al. A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol 1997;109:562-5.
9. Al-Heresh AM, Proctor J, Jones SM, Dixey J, Cox B, Welsh K, et al. Tumour necrosis factor-alpha polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis. Rheumatology (Oxford) 2002;41:525-30.
10. Balding J, Kane D, Livingstone W, Mynett-Johnson L, Bresnihan B, Smith O, et al. Cytokine gene polymorphisms: association with psoriatic arthritis susceptibility and severity. Arthritis Rheum 2003;48:1408-13.
11. Gonzalez S, Brautbar C, Martinez-Borra J, Lopez-Vazquez A, Segal R, Blanco-Gelaz MA, et al. Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population. Hum Immunol 2001;62:632-8.
12. Gonzalez S, Martinez-Borra J, Lopez-Vazquez A, Garcia-Fernandez S, Torre-Alonso JC, Lopez-Larrea C. MICA rather than MICB, TNFα, or HLA-DRB1 is associated with susceptibility to psoriatic arthritis. J Rheumatol 2002;29:973-8.
13. Hamamoto Y, Tateno H, Ishida T, Muto M. Lack of association between promoter polymorphism of the tumor necrosis factor-alpha gene and psoriatic arthritis in Japanese patients. J Invest Dermatol 2000;115:1162-4.
14. Mossner R, Kingo K, Kleensang A, Kruger U, Konig IR, Silm H, et al. Association of TNF -238 and -308 promoter polymorphisms with psoriasis vulgaris and psoriatic arthritis but not with pustulosis palmoplantaris. J Invest Dermatol 2005;124:282-4.
15. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995;12:921-7.
16. Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics 1997;53:1253-61.
17. Schaid DJ, Jacobsen SJ. Biased tests of association: Comparisons of allele frequencies when departing from Hardy-Weinberg proportions. Am J Epidemiol 1999;149:706-11.
18. Moll JM, Wright V. Familial occurrence of psoriatic arthritis. Ann Rheum Dis 1973;32:181-201.
19. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001;29:306-9.
20. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002;4(2):45-61.
21. Huizinga TW, Pisetsky DS, Kimberly RP. Associations, populations, and the truth: recommendations for genetic association studies in arthritis and rheumatism. Arthritis Rheum 2004;50:2066-71.
22. Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ionnidis DG. Genetic associations in large versus small studies: an empirical assessment. Lancet 2003;15:361, 567-71.